5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
about
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
@ast
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
@en
type
label
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
@ast
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
@en
prefLabel
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
@ast
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
@en
P2860
P1476
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
@en
P2093
David Robinson
Pär Stattin
P2860
P2888
P304
P356
10.1007/S10552-015-0622-4
P577
2015-06-25T00:00:00Z